Similar articles for PMID: 26629436

Year	Number of Results
1998	1
2001	2
2002	2
2005	1
2006	1
2008	1
2009	1
2010	2
2011	6
2012	4
2013	5
2014	3
2015	9
2016	10
2017	7
2018	9
2019	7
2021	1
2024	0

1

Maintenance sunitinib for extensive-stage small cell lung cancer: a new standard, an option or a step in the right direction?

Schneider BJ. Schneider BJ. Transl Lung Cancer Res. 2015 Oct;4(5):635-8. doi: 10.3978/j.issn.2218-6751.2015.06.03. Transl Lung Cancer Res. 2015. PMID: 26629436 Free PMC article.

2

Positive Interaction between Prophylactic Cranial Irradiation and Maintenance Sunitinib for Untreated Extensive-Stage Small Cell Lung Cancer Patients After Standard Chemotherapy: A Secondary Analysis of CALGB 30504 (ALLIANCE).

Salama JK, Gu L, Wang X, Pang HH, Bogart JA, Crawford J, Schild SE, Vokes EE, Ready NE. Salama JK, et al. J Thorac Oncol. 2016 Mar;11(3):361-9. doi: 10.1016/j.jtho.2015.11.001. Epub 2015 Dec 24. J Thorac Oncol. 2016. PMID: 26723241 Free PMC article. Clinical Trial.

3

Chemotherapy With or Without Maintenance Sunitinib for Untreated Extensive-Stage Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase II Study-CALGB 30504 (Alliance).

Ready NE, Pang HH, Gu L, Otterson GA, Thomas SP, Miller AA, Baggstrom M, Masters GA, Graziano SL, Crawford J, Bogart J, Vokes EE. Ready NE, et al. J Clin Oncol. 2015 May 20;33(15):1660-5. doi: 10.1200/JCO.2014.57.3105. Epub 2015 Mar 2. J Clin Oncol. 2015. PMID: 25732163 Free PMC article. Clinical Trial.

4

Phase II trial of sunitinib maintenance therapy after platinum-based chemotherapy in patients with extensive-stage small cell lung cancer.

Schneider BJ, Gadgeel SM, Ramnath N, Wozniak AJ, Dy GK, Daignault S, Kalemkerian GP. Schneider BJ, et al. J Thorac Oncol. 2011 Jun;6(6):1117-20. doi: 10.1097/JTO.0b013e31821529c3. J Thorac Oncol. 2011. PMID: 21512407 Free article. Clinical Trial.

5

Phase II study of maintenance sunitinib following irinotecan and carboplatin as first-line treatment for patients with extensive-stage small-cell lung cancer.

Spigel DR, Greco FA, Rubin MS, Shipley D, Thompson DS, Lubiner ET, Eakle JF, Quinn R, Burris HA, Hainsworth JD. Spigel DR, et al. Lung Cancer. 2012 Aug;77(2):359-64. doi: 10.1016/j.lungcan.2012.03.009. Epub 2012 May 3. Lung Cancer. 2012. PMID: 22560921 Clinical Trial.

6

Phase II study of oral etoposide maintenance for patients with extensive stage small cell lung cancer who have responded to the induction on an EP regimen.

Li L, Li Q, Xu Y, Huang M, Liu Y, Gong Y, Peng F, Zhou L, Ding Z, Ren L, Wang J, Lu Y, Zhu J, Hou M. Li L, et al. Thorac Cancer. 2013 Aug;4(3):234-240. doi: 10.1111/1759-7714.12019. Thorac Cancer. 2013. PMID: 28920253 Free article.

7

The benefits of etoposide capsules as maintenance therapy for patients with extensive-stage small cell lung cancer: a prospective two-stage, two-center study.

Zhang C, Duan J, He Z, Yang L, Yang S, Zhang Z, Liu Y, Wan R, Lin L, Wu X, Wang W, Wang Q, Wang J. Zhang C, et al. J Thorac Dis. 2021 Jan;13(1):343-352. doi: 10.21037/jtd-21-106. J Thorac Dis. 2021. PMID: 33569214 Free PMC article.

8

Advances in antiangiogenic treatment of small-cell lung cancer.

Lu H, Jiang Z. Lu H, et al. Onco Targets Ther. 2017 Jan 12;10:353-359. doi: 10.2147/OTT.S119714. eCollection 2017. Onco Targets Ther. 2017. PMID: 28138259 Free PMC article. Review.

9

Raising the bar for enthusiasm when looking at results of randomized phase II trials-the case of sunitinib in small-cell lung cancer.

Di Maio M, Bironzo P, Scagliotti GV. Di Maio M, et al. Transl Lung Cancer Res. 2016 Feb;5(1):89-91. doi: 10.3978/j.issn.2218-6751.2015.07.18. Transl Lung Cancer Res. 2016. PMID: 26958498 Free PMC article.

10

Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial.

Paz-Ares L, Dvorkin M, Chen Y, Reinmuth N, Hotta K, Trukhin D, Statsenko G, Hochmair MJ, Özgüroğlu M, Ji JH, Voitko O, Poltoratskiy A, Ponce S, Verderame F, Havel L, Bondarenko I, Kazarnowicz A, Losonczy G, Conev NV, Armstrong J, Byrne N, Shire N, Jiang H, Goldman JW; CASPIAN investigators. Paz-Ares L, et al. Lancet. 2019 Nov 23;394(10212):1929-1939. doi: 10.1016/S0140-6736(19)32222-6. Epub 2019 Oct 4. Lancet. 2019. PMID: 31590988 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

62 results

Results by year